Monopar Therapeutics Inc. Confirming Statement Regarding Authority to Execute Section 16(a) Reports

This filing is a confirming statement from Monopar Therapeutics Inc. regarding the authority granted by insider Nicole Sweeny to Quan A. Vu, Chandler D. Robinson, John Harrington, and Sean Cheatle to execute and file Section 16(a) reports (Forms 3, 4, and 5) on her behalf. This authorization pertains to her ownership of or transactions in the company's securities. The authority remains in effect until Sweeny is no longer required to file these forms, or until it is revoked in writing. The statement clarifies that the authorized signers are not assuming Sweeny's compliance responsibilities under Section 16 of the Securities Exchange Act of 1934.